Capstone Wealth Management Group LLC Acquires 1,811 Shares of Intuitive Surgical, Inc. $ISRG

Posted by Francis Steltz on Nov 12th, 2026

Capstone Wealth Management Group LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 151.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,006 shares of the medical equipment provider’s stock after acquiring an additional 1,811 shares during the quarter. Intuitive Surgical comprises 0.6% of Capstone Wealth Management Group LLC’s holdings, making the stock its 27th largest holding. Capstone Wealth Management Group LLC’s holdings in Intuitive Surgical were worth $1,344,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Fairscale Capital LLC grew its holdings in shares of Intuitive Surgical by 3.5% during the 3rd quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock worth $279,000 after purchasing an additional 22 shares during the period. Beaumont Financial Advisors LLC raised its holdings in Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 23 shares during the period. Hughes Financial Services LLC lifted its position in Intuitive Surgical by 40.7% in the third quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 24 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co lifted its position in Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock valued at $1,172,000 after buying an additional 25 shares during the last quarter. Finally, Blue Fin Capital Inc. boosted its stake in Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Mark Brosius sold 61 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the transaction, the executive vice president owned 581 shares in the company, valued at $256,569.60. The trade was a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 39,056 shares of company stock valued at $17,585,864. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $449.53 on Thursday. The stock’s 50-day moving average is $414.76 and its two-hundred day moving average is $430.83. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a market cap of $155.83 billion, a price-to-earnings ratio of 54.36, a price-to-earnings-growth ratio of 3.10 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.40 EPS. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ISRG shares. Royal Bank Of Canada dropped their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research report on Wednesday, October 21st. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Finally, Stifel Nicolaus cut their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

View Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.